Terra Bioware

What Terra Bioware does

Terra Bioware is an India-based, privately held biotech company that develops and supplies regenerative biomaterials through a microbial biomanufacturing platform. Founded in 2022 and headquartered in New Delhi, the company operates fermentation-based processes to produce polyhydroxyalkanoates (PHAs) and bioactive molecules positioned as biodegradable alternatives to petrochemical-derived plastics and as active ingredients for human regeneration. Its product surface is organized into three branded verticals: TERRAGEN, a skincare bioactive targeting skin longevity and regeneration pathways including COL1A1, SIRT1, FOXO3a, VEGF, and AMPK; TERRAGENX, a health/longevity bioactive for energy, metabolic health, and cognition powered by ATP, NAD+, AMPK, and sirtuin pathways; and TERRAPHA+, a MedTech regenerative biomaterial designed for tissue repair, surgical devices, and cell proliferation with high biocompatibility. Proprietary technology features described across sources include a closed-loop, modular, asset-light manufacturing architecture intended to minimize waste and emissions, though no patents, trademarks, certifications, or production-scale benchmarks are disclosed.

The company pursues a B2B ingredient-supplier model, selling regenerative biomaterials to enterprise customers in skincare, nutraceuticals, medical devices, and sustainable packaging. Customer acquisition is conducted through direct enterprise outreach supported by Typeform-based inquiry forms (separating customer and investor funnels), and the public website and LinkedIn page serve as top-of-funnel channels. Pricing is not publicly disclosed, and no commercial agreements, named brand customers, contract values, or revenue figures are documented. In April 2024, the company raised a pre-seed funding round led by Rebalance to support commercialization across its four target industries; the funding amount and post-money valuation are undisclosed. The leadership team listed in public sources consists of a single named executive, Shruti Singh, Founder & CEO.

Name

Terra Bioware

Legal name

Terra Bioware

Website

https://terrabioware.co

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Terra Bioware is an India-based biotech company that produces regenerative biomaterials via microbial biomanufacturing, supplying B2B ingredients under three product lines — TERAGEN (skincare), TERAGENX (nutraceuticals), and TERRAPHA+ (MedTech) — alongside biodegradable PHA bioplastics for packaging customers.

Ownership category

akta.pro rank

Product category

Regenerative Biomaterials

NAICS

Resin and Synthetic Rubber Manufacturing (32521), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Plastic Materials, Synth Resins & Nonvulcan Elastomers (2821), Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) (2820)

akta.pro primary industry

Bio-based & Biodegradable Polymer Resin Manufacturing (PLA, PHA, PBS, starch blends) (IMANAAAG)

akta.pro secondary industries

Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates) (IMAEAOAL), Compostable & Bio-Based Packaging (PLA/PHA, Starch Blends, Cellulose Films) (IMALAMAB)

Keywords

• Regenerative biomaterials
• Bioplastic manufacturing
• Bioactive ingredients
• Microbial biomanufacturing
• PHA production

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Biomaterial Ingredients B2B Sales: Terra Bioware supplies regenerative biomaterial ingredients to skincare, nutraceutical, medical device, and packaging companies. The company functions as an ingredient/supplier partner enabling brands to incorporate regenerative bioactives into their products.
2. PHA Bioplastics: Production and supply of biodegradable PHAs as replacements for petroplastics, targeting consumer product companies seeking sustainable packaging solutions.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Terra Bioware manufactures regenerative biomaterials via a microbial biomanufacturing platform and sells them as ingredient inputs to B2B customers. Its named offerings include TERAGEN (skincare bioactive), TERAGENX (nutraceutical/health bioactive), TERRAPHA+ (medtech regenerative biomaterial), and biodegradable PHA bioplastics for sustainable packaging. The company targets skincare, nutraceutical, medical device, and packaging brands seeking science-backed regenerative inputs.

Product overview

Terra Bioware operates a regenerative biomaterials platform that produces bioactive molecules for diverse applications across three verticals: TERAGEN (skincare), TERAGENX (health/nutraceuticals), and TERRAPHA+ (medical devices). The company leverages next-generation industrial biotechnology to manufacture regenerative biomaterials with high precision, consistency, and scalability, serving the skincare, nutraceutical, medical, and advanced biomaterials industries.

Differentiator

Problem solved

Functional benefit

Brands

• TERRAGEN: Bioactive for cell rejuvenation, longevity, hydration, and skin resilience. Enhances COL1A1, SIRT1, FOXO3a, VEGF, HAS2, AQP3, FASN, ATP, and AMPK pathways for skin longevity and regeneration.
• TERRAGENX
• TERRAPHA+

Products and services

• TERAGEN A skincare bioactive ingredient designed for cell rejuvenation, longevity, hydration, and skin resilience. Enhances COL1A1, SIRT1, FOXO3a, VEGF, HAS2, AQP3, FASN, ATP, and AMPK pathways for skin longevity and regeneration. Supplied as a regenerative bioactive ingredient to enterprise skincare and cosmetics brands.
• TERAGENX A health and nutraceutical bioactive ingredient that enhances energy, metabolic health, and cognition for healthy aging. Powered by ATP, NAD+, AMPK, Sirtuins, autophagy, mitophagy, HSP70, HSC70, and epigenetic longevity pathways. Supplied as a regenerative bioactive ingredient to enterprise nutraceutical and wellness brands.
• TERRAPHA+ An advanced regenerative biomaterial for medtech applications that promotes cell proliferation, tissue integration, and high biocompatibility. Designed for innovation in tissue repair and surgical devices. Supplied to enterprise medical device and medtech companies.
• PHA Bioplastics Fully biodegradable polyhydroxyalkanoates (PHAs) produced via microbial fermentation as climate-positive replacements for petroplastics in consumer packaging applications. Supplied as a sustainable biomaterial to consumer product and packaging companies.

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Danimer Scientific: Commercial-scale producer of PHA bioplastics (Nodax brand) for packaging and single-use applications. Directly comparable to Terra Bioware's PHA bioplastics business in technology and end-market, though at far greater scale and capital intensity.
• Mango Materials: US-based PHA bioplastics producer using microbial fermentation of waste gases. Closely comparable to Terra Bioware on the PHA biomanufacturing platform and packaging end-market, though more mature on the waste-to-materials feedstock innovation.
• Newlight Technologies: Producer of PHA bioplastic (AirCarbon) made from greenhouse gas-derived microbial fermentation. Direct competitor to Terra Bioware's PHA bioplastics offering, using a similar fermentation-based platform for sustainable packaging.

Broad incumbents

• Kaneka Corporation: Established Japanese chemical company producing PHB/PHA biopolymers (Kaneka PHBH) and a broad specialty chemicals portfolio. Comparable to Terra Bioware on PHA resin manufacturing, with far deeper commercial and regulatory infrastructure.
• Corbion: Global specialty chemicals and food ingredients company with bioplastics (including PHA partnerships) and biomedical polymers (PURAC biomaterials for medical devices). Comparable to Terra Bioware on both the PHA and medical-grade biomaterial axes, though at incumbent scale.
• Evonik Industries: Specialty chemicals major with a Health Care division producing bioresorbable polymers (RESOMER) for medical devices and a portfolio of cosmetic actives. Comparable to Terra Bioware's TERRAPHA+ and TERAGEN offerings, as an established incumbent in adjacent biomaterial categories.

Emerging players

• Yield10 Bioscience: Biotech company developing PHA-producing camelina and other crop platforms. Comparable to Terra Bioware as a PHA developer, but with a plant-based rather than microbial fermentation route, representing an alternative technical pathway in the same end-markets.
• Amyris: Fermentation-based ingredient company producing bioactives for skincare, nutrition, and flavors. Comparable to Terra Bioware on the microbial biomanufacturing platform and the skincare/nutraceutical ingredient business model, though Amyris has experienced significant commercial and financial turbulence.
• Geltor: Animal-free protein ingredients for skincare and personal care produced via precision fermentation. Comparable to Terra Bioware's TERAGEN bioactive for skincare, sharing the B2B fermentation-derived ingredient model and prestige beauty customer base.
• LanzaTech: Carbon capture company using gas fermentation to produce fuels and chemicals, including PHA precursors. Comparable to Terra Bioware on the microbial gas/substrate fermentation platform and climate-positive positioning, with significantly more capital and scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/terra-bioware

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terra Bioware